Nurix Therapeutics, Inc. (NRIX) Balance Sheet
As of 2026-08-31 (10-Q), Nurix Therapeutics, Inc. (NRIX) reported total assets of $1.2B, total liabilities of $227.0M and shareholders' equity of $968.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $720.2M.
Source: SEC EDGAR filings · figures as of 2026-08-31 · read by EquiReason
NRIXNurix Therapeutics, Inc.Follow NRIX — free
—
Price chart with a free account
- Market cap
- 2.8B
- P/E TTM
- 10.0
- Dividend yield
- 0.0%
- 52-week
- —
- Next earnings
- 26 Jan, in 94 days
| Line | FY2020 Nov 20 | FY2021 Nov 21 | FY2022 Nov 22 | FY2023 Nov 23 | FY2024 Nov 24 | FY2025 Nov 25 | Latest Aug 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.12 | 0.08 | 0.06 | 0.05 | 0.11 | 0.25 | 0.72 | |
| Short-term investments | 0.16 | 0.22 | 0.24 | — | — | — | — | |
| Receivables | — | 0.01 | 0.00 | — | 0.00 | 0.00 | 0.02 | |
| Current assets | 0.30 | 0.31 | 0.32 | 0.30 | 0.62 | 0.61 | 1.10 | |
| Total assets | 0.40 | 0.48 | 0.42 | 0.36 | 0.67 | 0.69 | 1.20 | |
| Current liabilities | 0.04 | 0.07 | 0.07 | 0.09 | 0.10 | 0.09 | 0.13 | |
| Total liabilities | 0.11 | 0.13 | 0.11 | 0.16 | 0.14 | 0.15 | 0.23 | |
| Shareholders' equity | 0.29 | 0.34 | 0.30 | 0.20 | 0.53 | 0.54 | 0.97 |
USD billions · SEC XBRL
Nurix Therapeutics, Inc. — questions
- How much cash does Nurix Therapeutics, Inc. have?
- $720.2M in cash and cash equivalents as of 2026-08-31.
- What are Nurix Therapeutics, Inc.'s total assets?
- $1.2B as of 2026-08-31.
- What is Nurix Therapeutics, Inc.'s shareholders' equity?
- $968.3M as of 2026-08-31.
Every figure on this page comes from Nurix Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.